Clinical Trials List
Protocol NumberEMR 63325-001
Phase III
Terminated2
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 林育麟 Division of Hematology & Oncology
- 陳冠宇 Division of Thoracic Medicine
- 林宗哲 Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Thoracic Medicine
- Chiun Hsu Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Thoracic Medicine
- Chong-Jen Yu Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 劉美瑾 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
100 participants
-
Global
1322 participants
